Application of eltrombopag
The invention relates to an application of a compound eltrombopag as shown in a formula I, a solvate of the eltrombopag or a pharmaceutically acceptable salt of the eltrombopag. The application comprises the following steps: (i) inhibiting binding of TFEb and a CLEAR DNA sequence; (ii) inhibiting th...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
05.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to an application of a compound eltrombopag as shown in a formula I, a solvate of the eltrombopag or a pharmaceutically acceptable salt of the eltrombopag. The application comprises the following steps: (i) inhibiting binding of TFEb and a CLEAR DNA sequence; (ii) inhibiting the transcriptional level of a TFEb downstream lysosome related gene; (iii) inhibiting cell autophagy; (iv) preventing and/or treating tumors. # imgabs0 #
本发明涉及一种式I化合物艾曲波帕、其溶剂化物、或其药学上可接受的盐的用途,包括:(i)抑制TFEb与CLEAR DNA序列的结合;(ii)抑制TFEb下游溶酶体相关基因的转录水平;(iii)抑制细胞自噬;(iv)预防和/治疗肿瘤。#imgabs0# |
---|---|
Bibliography: | Application Number: CN20231009586 |